Charles River Laboratories International Inc (NYSE:CRL)

217.62
Delayed Data
As of 3:59pm ET
 -2.53 / -1.15%
Today’s Change
203.37
Today|||52-Week Range
460.21
-42.24%
Year-to-Date
Charles River (CRL) Business Hurt by Macro and FX Headwinds
Aug 16 / Zacks.com - Paid Partner Content
Top 5 2nd Quarter Trades of Jackson Square Partners, LLC
Aug 14 / GuruFocus News - Paid Partner Content
Tower House Partners LLP's Top 5 Sells of the 2nd Quarter
Aug 15 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close220.15
Today’s open220.05
Day’s range216.35 - 220.15
Volume540,846
Average volume (3 months)543,544
Market cap$11.9B
Data as of 3:59pm ET, 08/19/2022

Growth & Valuation

Earnings growth (last year)+5.74%
Earnings growth (this year)+5.63%
Earnings growth (next 5 years)+14.50%
Revenue growth (last year)+21.08%
P/E ratio25.3
Price/Sales5.36
Price/Book4.64

Competitors

----
SYNHSyneos Health Inc-0.93-1.39%
EXELExelixis Inc+0.12+0.60%
MEDPMedpace Holdings Inc-3.23-1.85%
Data as of 4:00pm ET, 08/19/2022

Financials

Next reporting dateNovember 2, 2022
EPS forecast (this quarter)$2.58
Annual revenue (last year)$3.5B
Annual profit (last year)$391.0M
Net profit margin11.04%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
No executives to display
Corporate headquarters
Wilmington, Massachusetts

Forecasts